(Q73268238)
Statements
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results (English)
M Dietlein
K Weber
A Gandjour
D Moka
P Theissen
K W Lauterbach